SEC Form 4 · accession 0001166280-15-000001
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack Lief
Officer — President and CEO · Director
Period of report
Mar 3, 2015
Accepted (ET)
Mar 4, 2015 · 5:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 3, 2015 | M | 125,000 | $1.49 | A | 622,189 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.49 | Mar 3, 2015 | M | 125,000 | D | — | Mar 15, 2021 | Common Stock | 125,000 | 75,000 | D |
Explanation of responses
- F1The options, representing a right to purchase a total of 300,000 shares, vest in four equal annual installments, and are exercisable once vested. The first, second and third installments became exercisable on March 15, 2012, 2013, and 2014, respectively, and the fourth installment vests on March 15, 2015.